Hyundai Pharmaceutical Co., Ltd. (KRX:004310)

South Korea flag South Korea · Delayed Price · Currency is KRW
9,300.00
+100.00 (1.09%)
Mar 20, 2026, 10:10 AM KST
Market Cap254.63B +166.3%
Revenue (ttm)108.14B +5.8%
Net Income1.41B
EPS60.34
Shares Out27.68M
PE Ratio152.47
Forward PEn/a
Dividend30.00 (0.32%)
Ex-Dividend DateMar 3, 2026
Volume391,609
Average Volume1,278,875
Open9,200.00
Previous Close9,200.00
Day's Range9,160.00 - 9,670.00
52-Week Range2,995.00 - 15,960.00
Beta0.79
RSI38.18
Earnings Daten/a

About Hyundai Pharmaceutical

Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical devices in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antianginal, antibiotic, antiemetics+antinauseants, antihistamines and antiallergics, antihyperlipidemic, antihypertensive, antiplatelet agent, antitussives, cell stimulants and proliferants, central nervous system, depilatory, dermatological agent, dermatology, dietary supplements, digestive sy... [Read more]

Sector Healthcare
Founded 1965
Employees 393
Stock Exchange Korea Stock Exchange
Ticker Symbol 004310
Full Company Profile

Financial Performance

Financial Statements